Clinical trial
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas…
NCT00178763 · The University of Texas Health Science Center, Houston, Other · Unknown status
Key facts
| NCT number | NCT00178763 |
|---|---|
| Title | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer |
| Official title | Phase II Clinical Trial of Cisplatin + Gemcitabine in Combination With Mild, Fever-Range Whole-Body Hyperthermia to Treat Patients With Advanced, Inoperable Pancreatic Cancer |
| Acronym | FR-WB-TT |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasms |
| Intervention type | Device, Other |
| Interventions | Heckel Infrared Radiant Heat Device, cisplatin, gemcitabine, interferon-alpha, thermochemotherapy |
| Enrollment | 36 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2013 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: